The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Melphalan Injection Market Research Report 2024
Synopsis
It is an anti-tumor drug.It is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate.
The global Melphalan Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Melphalan Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Melphalan Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Melphalan Injection include Fresenius Kabi, Dr. Reddy's, Athenex, Meitheal Pharmaceutical, GSK, Mylan, Sagent, Spectrum Pharmaceuticals and Par Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Melphalan Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melphalan Injection.
Report Scope
The Melphalan Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Melphalan Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Melphalan Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fresenius Kabi
Dr. Reddy's
Athenex
Meitheal Pharmaceutical
GSK
Mylan
Sagent
Spectrum Pharmaceuticals
Par Pharmaceuticals
Mediclone Biotech
Segment by Type
50mg/vial
10mg/vial
Segment by Application
Hospital
Clinics
Recovery Center
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Melphalan Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Melphalan Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
It is an anti-tumor drug.It is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate.
The global Melphalan Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Melphalan Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Melphalan Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Melphalan Injection include Fresenius Kabi, Dr. Reddy's, Athenex, Meitheal Pharmaceutical, GSK, Mylan, Sagent, Spectrum Pharmaceuticals and Par Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Melphalan Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melphalan Injection.
Report Scope
The Melphalan Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Melphalan Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Melphalan Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fresenius Kabi
Dr. Reddy's
Athenex
Meitheal Pharmaceutical
GSK
Mylan
Sagent
Spectrum Pharmaceuticals
Par Pharmaceuticals
Mediclone Biotech
Segment by Type
50mg/vial
10mg/vial
Segment by Application
Hospital
Clinics
Recovery Center
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Melphalan Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Melphalan Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Melphalan Injection Market Overview
1.1 Product Overview and Scope of Melphalan Injection
1.2 Melphalan Injection Segment by Type
1.2.1 Global Melphalan Injection Market Value Comparison by Type (2024-2030)
1.2.2 50mg/vial
1.2.3 10mg/vial
1.3 Melphalan Injection Segment by Application
1.3.1 Global Melphalan Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Recovery Center
1.4 Global Melphalan Injection Market Size Estimates and Forecasts
1.4.1 Global Melphalan Injection Revenue 2019-2030
1.4.2 Global Melphalan Injection Sales 2019-2030
1.4.3 Global Melphalan Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Melphalan Injection Market Competition by Manufacturers
2.1 Global Melphalan Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Melphalan Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Melphalan Injection Average Price by Manufacturers (2019-2024)
2.4 Global Melphalan Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Melphalan Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Melphalan Injection, Product Type & Application
2.7 Melphalan Injection Market Competitive Situation and Trends
2.7.1 Melphalan Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Melphalan Injection Players Market Share by Revenue
2.7.3 Global Melphalan Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Melphalan Injection Retrospective Market Scenario by Region
3.1 Global Melphalan Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Melphalan Injection Global Melphalan Injection Sales by Region: 2019-2030
3.2.1 Global Melphalan Injection Sales by Region: 2019-2024
3.2.2 Global Melphalan Injection Sales by Region: 2025-2030
3.3 Global Melphalan Injection Global Melphalan Injection Revenue by Region: 2019-2030
3.3.1 Global Melphalan Injection Revenue by Region: 2019-2024
3.3.2 Global Melphalan Injection Revenue by Region: 2025-2030
3.4 North America Melphalan Injection Market Facts & Figures by Country
3.4.1 North America Melphalan Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Melphalan Injection Sales by Country (2019-2030)
3.4.3 North America Melphalan Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Melphalan Injection Market Facts & Figures by Country
3.5.1 Europe Melphalan Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Melphalan Injection Sales by Country (2019-2030)
3.5.3 Europe Melphalan Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Melphalan Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Melphalan Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Melphalan Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Melphalan Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Melphalan Injection Market Facts & Figures by Country
3.7.1 Latin America Melphalan Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Melphalan Injection Sales by Country (2019-2030)
3.7.3 Latin America Melphalan Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Melphalan Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Melphalan Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Melphalan Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Melphalan Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Melphalan Injection Sales by Type (2019-2030)
4.1.1 Global Melphalan Injection Sales by Type (2019-2024)
4.1.2 Global Melphalan Injection Sales by Type (2025-2030)
4.1.3 Global Melphalan Injection Sales Market Share by Type (2019-2030)
4.2 Global Melphalan Injection Revenue by Type (2019-2030)
4.2.1 Global Melphalan Injection Revenue by Type (2019-2024)
4.2.2 Global Melphalan Injection Revenue by Type (2025-2030)
4.2.3 Global Melphalan Injection Revenue Market Share by Type (2019-2030)
4.3 Global Melphalan Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Melphalan Injection Sales by Application (2019-2030)
5.1.1 Global Melphalan Injection Sales by Application (2019-2024)
5.1.2 Global Melphalan Injection Sales by Application (2025-2030)
5.1.3 Global Melphalan Injection Sales Market Share by Application (2019-2030)
5.2 Global Melphalan Injection Revenue by Application (2019-2030)
5.2.1 Global Melphalan Injection Revenue by Application (2019-2024)
5.2.2 Global Melphalan Injection Revenue by Application (2025-2030)
5.2.3 Global Melphalan Injection Revenue Market Share by Application (2019-2030)
5.3 Global Melphalan Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Fresenius Kabi
6.1.1 Fresenius Kabi Corporation Information
6.1.2 Fresenius Kabi Description and Business Overview
6.1.3 Fresenius Kabi Melphalan Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Fresenius Kabi Melphalan Injection Product Portfolio
6.1.5 Fresenius Kabi Recent Developments/Updates
6.2 Dr. Reddy's
6.2.1 Dr. Reddy's Corporation Information
6.2.2 Dr. Reddy's Description and Business Overview
6.2.3 Dr. Reddy's Melphalan Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Dr. Reddy's Melphalan Injection Product Portfolio
6.2.5 Dr. Reddy's Recent Developments/Updates
6.3 Athenex
6.3.1 Athenex Corporation Information
6.3.2 Athenex Description and Business Overview
6.3.3 Athenex Melphalan Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Athenex Melphalan Injection Product Portfolio
6.3.5 Athenex Recent Developments/Updates
6.4 Meitheal Pharmaceutical
6.4.1 Meitheal Pharmaceutical Corporation Information
6.4.2 Meitheal Pharmaceutical Description and Business Overview
6.4.3 Meitheal Pharmaceutical Melphalan Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Meitheal Pharmaceutical Melphalan Injection Product Portfolio
6.4.5 Meitheal Pharmaceutical Recent Developments/Updates
6.5 GSK
6.5.1 GSK Corporation Information
6.5.2 GSK Description and Business Overview
6.5.3 GSK Melphalan Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GSK Melphalan Injection Product Portfolio
6.5.5 GSK Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Melphalan Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mylan Melphalan Injection Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Sagent
6.6.1 Sagent Corporation Information
6.6.2 Sagent Description and Business Overview
6.6.3 Sagent Melphalan Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sagent Melphalan Injection Product Portfolio
6.7.5 Sagent Recent Developments/Updates
6.8 Spectrum Pharmaceuticals
6.8.1 Spectrum Pharmaceuticals Corporation Information
6.8.2 Spectrum Pharmaceuticals Description and Business Overview
6.8.3 Spectrum Pharmaceuticals Melphalan Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Spectrum Pharmaceuticals Melphalan Injection Product Portfolio
6.8.5 Spectrum Pharmaceuticals Recent Developments/Updates
6.9 Par Pharmaceuticals
6.9.1 Par Pharmaceuticals Corporation Information
6.9.2 Par Pharmaceuticals Description and Business Overview
6.9.3 Par Pharmaceuticals Melphalan Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Par Pharmaceuticals Melphalan Injection Product Portfolio
6.9.5 Par Pharmaceuticals Recent Developments/Updates
6.10 Mediclone Biotech
6.10.1 Mediclone Biotech Corporation Information
6.10.2 Mediclone Biotech Description and Business Overview
6.10.3 Mediclone Biotech Melphalan Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Mediclone Biotech Melphalan Injection Product Portfolio
6.10.5 Mediclone Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Melphalan Injection Industry Chain Analysis
7.2 Melphalan Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Melphalan Injection Production Mode & Process
7.4 Melphalan Injection Sales and Marketing
7.4.1 Melphalan Injection Sales Channels
7.4.2 Melphalan Injection Distributors
7.5 Melphalan Injection Customers
8 Melphalan Injection Market Dynamics
8.1 Melphalan Injection Industry Trends
8.2 Melphalan Injection Market Drivers
8.3 Melphalan Injection Market Challenges
8.4 Melphalan Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Melphalan Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Melphalan Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Melphalan Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Melphalan Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Melphalan Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Melphalan Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Melphalan Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Melphalan Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Melphalan Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Melphalan Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Melphalan Injection, Product Type & Application
Table 12. Global Key Manufacturers of Melphalan Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Melphalan Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melphalan Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Melphalan Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Melphalan Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Melphalan Injection Sales Market Share by Region (2019-2024)
Table 19. Global Melphalan Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Melphalan Injection Sales Market Share by Region (2025-2030)
Table 21. Global Melphalan Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Melphalan Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Melphalan Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Melphalan Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Melphalan Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Melphalan Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Melphalan Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Melphalan Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Melphalan Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Melphalan Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Melphalan Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Melphalan Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Melphalan Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Melphalan Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Melphalan Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Melphalan Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Melphalan Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Melphalan Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Melphalan Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Melphalan Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Melphalan Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Melphalan Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Melphalan Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Melphalan Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Melphalan Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Melphalan Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Melphalan Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Melphalan Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Melphalan Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Melphalan Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Melphalan Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Melphalan Injection Sales Market Share by Type (2019-2024)
Table 53. Global Melphalan Injection Sales Market Share by Type (2025-2030)
Table 54. Global Melphalan Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Melphalan Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Melphalan Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Melphalan Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Melphalan Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Melphalan Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Melphalan Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Melphalan Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Melphalan Injection Sales Market Share by Application (2019-2024)
Table 63. Global Melphalan Injection Sales Market Share by Application (2025-2030)
Table 64. Global Melphalan Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Melphalan Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Melphalan Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Melphalan Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Melphalan Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Melphalan Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Fresenius Kabi Corporation Information
Table 71. Fresenius Kabi Description and Business Overview
Table 72. Fresenius Kabi Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Fresenius Kabi Melphalan Injection Product
Table 74. Fresenius Kabi Recent Developments/Updates
Table 75. Dr. Reddy's Corporation Information
Table 76. Dr. Reddy's Description and Business Overview
Table 77. Dr. Reddy's Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Dr. Reddy's Melphalan Injection Product
Table 79. Dr. Reddy's Recent Developments/Updates
Table 80. Athenex Corporation Information
Table 81. Athenex Description and Business Overview
Table 82. Athenex Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Athenex Melphalan Injection Product
Table 84. Athenex Recent Developments/Updates
Table 85. Meitheal Pharmaceutical Corporation Information
Table 86. Meitheal Pharmaceutical Description and Business Overview
Table 87. Meitheal Pharmaceutical Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Meitheal Pharmaceutical Melphalan Injection Product
Table 89. Meitheal Pharmaceutical Recent Developments/Updates
Table 90. GSK Corporation Information
Table 91. GSK Description and Business Overview
Table 92. GSK Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. GSK Melphalan Injection Product
Table 94. GSK Recent Developments/Updates
Table 95. Mylan Corporation Information
Table 96. Mylan Description and Business Overview
Table 97. Mylan Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Mylan Melphalan Injection Product
Table 99. Mylan Recent Developments/Updates
Table 100. Sagent Corporation Information
Table 101. Sagent Description and Business Overview
Table 102. Sagent Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Sagent Melphalan Injection Product
Table 104. Sagent Recent Developments/Updates
Table 105. Spectrum Pharmaceuticals Corporation Information
Table 106. Spectrum Pharmaceuticals Description and Business Overview
Table 107. Spectrum Pharmaceuticals Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Spectrum Pharmaceuticals Melphalan Injection Product
Table 109. Spectrum Pharmaceuticals Recent Developments/Updates
Table 110. Par Pharmaceuticals Corporation Information
Table 111. Par Pharmaceuticals Description and Business Overview
Table 112. Par Pharmaceuticals Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Par Pharmaceuticals Melphalan Injection Product
Table 114. Par Pharmaceuticals Recent Developments/Updates
Table 115. Mediclone Biotech Corporation Information
Table 116. Mediclone Biotech Description and Business Overview
Table 117. Mediclone Biotech Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Mediclone Biotech Melphalan Injection Product
Table 119. Mediclone Biotech Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Melphalan Injection Distributors List
Table 123. Melphalan Injection Customers List
Table 124. Melphalan Injection Market Trends
Table 125. Melphalan Injection Market Drivers
Table 126. Melphalan Injection Market Challenges
Table 127. Melphalan Injection Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Melphalan Injection
Figure 2. Global Melphalan Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Melphalan Injection Market Share by Type in 2023 & 2030
Figure 4. 50mg/vial Product Picture
Figure 5. 10mg/vial Product Picture
Figure 6. Global Melphalan Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Melphalan Injection Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinics
Figure 10. Recovery Center
Figure 11. Global Melphalan Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Melphalan Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Melphalan Injection Sales (2019-2030) & (K Units)
Figure 14. Global Melphalan Injection Average Price (US$/Unit) & (2019-2030)
Figure 15. Melphalan Injection Report Years Considered
Figure 16. Melphalan Injection Sales Share by Manufacturers in 2023
Figure 17. Global Melphalan Injection Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Melphalan Injection Players: Market Share by Revenue in 2023
Figure 19. Melphalan Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Melphalan Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Melphalan Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Melphalan Injection Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Melphalan Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Melphalan Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Melphalan Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Melphalan Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Melphalan Injection Sales Market Share by Country (2019-2030)
Figure 45. Latin America Melphalan Injection Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Melphalan Injection Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Melphalan Injection Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Melphalan Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Melphalan Injection by Type (2019-2030)
Figure 55. Global Revenue Market Share of Melphalan Injection by Type (2019-2030)
Figure 56. Global Melphalan Injection Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Melphalan Injection by Application (2019-2030)
Figure 58. Global Revenue Market Share of Melphalan Injection by Application (2019-2030)
Figure 59. Global Melphalan Injection Price (US$/Unit) by Application (2019-2030)
Figure 60. Melphalan Injection Value Chain
Figure 61. Melphalan Injection Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
